Ian H. Frazer

37 Kent Street
Woolloongabba, QLD 4102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

IL-33/IL1RL1 (ST2) signalling drives immune suppression in squamous intraepithelial hyperplasia.

IL-33/IL1RL1 (ST2) signalling drives immune suppression in squamous intraepithelial hyperplasia.

Journal: Tumour virus research

Published: January 14, 2026

Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.

Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.

Journal: Redox biology

Published: November 10, 2025

Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types.

Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types.

Journal: bioRxiv : the preprint server for biology

Published: August 06, 2025

The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases.

The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases.

Journal: The Journal of investigative dermatology

Published: January 29, 2025

STING Nanoagonist Boosts Antitumor Immunity of Therapeutic DNA Vaccines.

STING Nanoagonist Boosts Antitumor Immunity of Therapeutic DNA Vaccines.

Journal: Nano letters

Published: December 02, 2024

Spatial analysis of HPV-associated cervical intraepithelial neoplastic tissues demonstrate distinct immune signatures associated with cervical cancer progression.

Spatial analysis of HPV-associated cervical intraepithelial neoplastic tissues demonstrate distinct immune signatures associated with cervical cancer progression.

Journal: The Journal of pathology

Published: November 01, 2024

Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine.

Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine.

Journal: Nature communications

Published: October 08, 2024

Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen-processing-presentation machinery and poor patient survival.

Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen-processing-presentation machinery and poor patient survival.

Journal: Clinical & translational immunology

Published: August 20, 2024

Caerin 1.1/1.9-mediated antitumor immunity depends on IFNAR-Stat1 signalling of tumour infiltrating macrophage by autocrine IFNα and is enhanced by CD47 blockade.

Caerin 1.1/1.9-mediated antitumor immunity depends on IFNAR-Stat1 signalling of tumour infiltrating macrophage by autocrine IFNα and is enhanced by CD47 blockade.

Journal: Scientific reports

Published: July 29, 2024

A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.

A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.

Journal: Frontiers in oncology

Published: April 17, 2024

Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.

Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.

Journal: mSphere

Published: March 26, 2024

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Journal: Journal for immunotherapy of cancer

Published: January 11, 2024

Showing 1-12 of 135

Last Updated: 09/26/2026